<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">T cell receptor b-chain repertoire in inclusion body myositis</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Ing-Marie</forename><surname>Fyhr</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Pathology</orgName>
								<orgName type="institution">Gothenburg UniÕersity</orgName>
								<address>
									<settlement>Gothenburg</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ali-Reza</forename><surname>Moslemi</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Pathology</orgName>
								<orgName type="institution">Gothenburg UniÕersity</orgName>
								<address>
									<settlement>Gothenburg</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christopher</forename><surname>Lindberg</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution">Gothenburg UniÕersity</orgName>
								<address>
									<settlement>Gothenburg</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Anders</forename><surname>Oldfors</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Pathology</orgName>
								<orgName type="institution">Gothenburg UniÕersity</orgName>
								<address>
									<settlement>Gothenburg</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">T cell receptor b-chain repertoire in inclusion body myositis</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">5668C8FEA779765A328471BAA0124AE3</idno>
					<note type="submission">Received 13 April 1998; revised 26 May 1998; accepted 11 June 1998</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2" ident="GROBID" when="2023-03-30T18:12+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Inclusion body myositis</term>
					<term>T cell receptor</term>
					<term>Complementarity determining region 3</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Inclusion body myositis IBM is the most common muscle disease affecting individuals over 50 years of age. The inflammatory reaction is characterized by cell infiltrates predominated by CD8 q cytotoxic T cells. To analyze clonality of muscle infiltrating Ž . Ž . lymphocytes, we studied the complementarity determining region 3 CDR3 length distribution of the T cell receptor TCR . Muscle Ž . infiltrating lymphocytes were studied in three IBM patients and compared with peripheral blood lymphocytes PBL in two of these Ž . patients. The study was performed by reverse transcription polymerase chain reaction RT-PCR of RNA extracted from muscle tissue and PBL followed by analysis of fragment length distribution of the CDR3 region in each of 24 different Vb families. There was a restricted usage of TCR Vb gene families in muscle infiltrating T cells in all three patients. Some of the TCR Vb gene families showed oligoclonal expansions but polyclonal patterns were dominating. The CDR3 distribution of most Vb families differed between muscle infiltrating lymphocytes and PBL indicating that T cells have expanded locally or selectively accumulated in muscle.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">Introduction</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ž</head><p>. Inclusion body myositis IBM is an inflammatory muscle disease affecting elderly people and is the most common muscle disease affecting individuals older than 50 Ž . years <ref type="bibr" target="#b4">Carpenter, 1996 .</ref> Clinically IBM is characterized by insidious onset of slowly progressive proximal and Ž distal muscle weakness <ref type="bibr" target="#b15">Lotz et al., 1989;</ref><ref type="bibr" target="#b13">Lindberg et al., . 1994b</ref> . The disease is in most cases refractory to immunosuppressive therapy in contrast to polymyositis and der-Ž . matomyositis <ref type="bibr" target="#b1">Barohn et al., 1995 .</ref> The diagnostic histopathologic findings are muscle fibers with rimmed vacuoles, 15-18 nm filamentous inclusions, amyloid de-Ž posits and interstitial inflammatory cell infiltrates <ref type="bibr" target="#b9">Griggs . et al., 1995 .</ref> The muscle infiltrating inflammatory cells are predominated by CD8 q cytotoxic T lymphocytes, which invade nonnecrotic MHC class I expressing muscle fibers Ž . <ref type="bibr" target="#b0">Arahata and Engel, 1988</ref> . Earlier studies have shown that Ž . there is a restricted usage of T cell receptor TCR variable Ž . Ž V b families in <ref type="bibr">IBM Lindberg et al., 1994a</ref>   <ref type="bibr">al., 1994;</ref><ref type="bibr" target="#b7">Fyhr et al., 1996 .</ref> Studies on a few Vb families have shown presence of oligoclonal expansions of muscle Ž infiltrating T cells <ref type="bibr" target="#b18">O'Hanlon et al., 1994;</ref><ref type="bibr" target="#b6">Fyhr et al., . 1997;</ref><ref type="bibr" target="#b2">Bender et al., 1998 .</ref> In this investigation we have used a recently established molecular approach to analyze Ž clonality for each TCR Vb gene segment <ref type="bibr" target="#b19">Pannetier et al., . 1993</ref> . The length distribution of the complementarity Ž . determining region 3 CDR3 of 24 TCR Vb gene families in muscle infiltrating T cells was analyzed. In two of the three analyzed patients the muscle infiltrating lymphocytes were compared with corresponding peripheral blood lym-Ž . phocytes PBL .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Materials and methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.1.">Patients and muscle biopsies</head><p>Three IBM patients were included in the study. A summary of clinical data is shown in Table <ref type="table">1</ref>. The patients had progressive muscle weakness and diagnostic criteria for IBM was invasion of nonnecrotic fibers by mononuclear cells, muscle fibers with rimmed vacuoles and collec-Ž . tions of 15-18 nm tubulofilaments <ref type="bibr" target="#b9">Griggs et al., 1995</ref> 0165-5728r98r$ -see front matter q 1998 Elsevier Science B.V. All rights reserved.</p><p>Ž . PII: S <ref type="table" target="#tab_2">0 1 6 5 -5 7 2 8 9 8 0 0 1 6 3 -</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ž</head><p>. Fig. <ref type="figure">1</ref> . The muscle tissue specimens were obtained from the vastus lateralis of the quadriceps femoris muscle by open biopsy and were immediately frozen in a mixture of propane and propylene chilled by liquid nitrogen and kept at y708C until analyzed. Peripheral blood lymphocytes Ž . PBL from patient 1 and 2 were isolated by separation on Ž Ficoll-sodium diatrizoate sodium gradient Ficoll-Paque, . Pharmacia, Uppsala, Sweden .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2.">mRNA extraction and cDNA synthesis</head><p>Total RNA was extracted from 20 to 60 mg muscle tissue by guanidinium thiocyanate-phenol-chloroform ex-Ž traction RNAgents Total RNA Isolation System; Promega, . Ž Madison, WI and RNA from PBL was extracted Qiashredder lysat homogenis RNeasy total RNA kit; Qiagen, . Hilden, Germany according to the manufacturer. Synthesis of first strand cDNA was performed from 0.2-1 mg Ž RNA Ready To Go you-prime first-strand beads; Pharma-. cia, Uppsala, Sweden .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3.">PCR amplification</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ž</head><p>. Polymerase chain reaction PCR analysis was performed with 25 pmol of forward and reverse primers Ž .  denaturation at 948C for 30 s, annealing of primers at 588C for 30 s and extension of primers at 728C for 30 s. The second PCR amplification was performed in the same way but with the Cb primer conjugated to a fluorescent dye Ž . 6-FAM KEBO Lab, Stockholm, Sweden .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4.">CDR3 analysis</head><p>One microliter of the labeled PCR products was loaded Ž on a 4.8% polyacrylamide sequencing gel Amresco, Solon, . Ž Oh and run on an automated DNA sequencer Model 377 . DNA Sequencer, Applied Biosystems, Foster City, CA in the presence of fluorescent size markers. The length and the relative intensity of the labeled PCR products was Ž determined by using Genescane Analysis software Perkin . Elmer, Foster City, CA . Since the positions of the Vb and the Cb primers were fixed, the length distribution observed in the PCR fluorescent Vb-Cb products only depended on the size of the CDR3 region, which was set Ž . according to <ref type="bibr" target="#b17">Moss Moss and Bell, 1995</ref> . Potential oligoclonal T cell expansions were identified by predominant peak area corresponding to more than 50% of the total Ž . signal present in the subfamily <ref type="bibr" target="#b16">Monteiro et al., 1995 .</ref> All samples were investigated at least twice and many of the samples needed to be diluted before the analysis.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">Results</head><p>To study the degree of clonality of muscle infiltrating lymphocytes in IBM the size spectrum of the CDR3 region of 24 different Vb families was determined. First, analysis of PBL from a healthy 35-year old individual was per-Ž . formed Fig. <ref type="figure">2a</ref> . In this case the size spectrum of the CDR3 region showed an expected Gaussian-like distribution in most Vb families indicating a polyclonal popula-Ž . tion of T cells <ref type="bibr" target="#b5">Even et al., 1995 .</ref> Then we studied Vb family gene expression in muscle tissue from three patients Ž . with IBM Fig. <ref type="figure">2b and c</ref> . Most but not all Vb families were detected. Thus, in patient 1 TCR Vb9, 11, 12, 16 and 23 were not detected. Patient 2 showed absence of TCR Vb2, 5.2, 10, 16 and 23. In patient 3 TCR Vb19 was not detected. The size distribution of the CDR3 region varied from a polyclonal to an oligoclonal or monoclonal pattern. By defining potential oligoclonal expansions as peaks representing more than 50% of the total peak area we found such expansions in TCR <ref type="bibr">Vb2,</ref><ref type="bibr">10,</ref><ref type="bibr">19,</ref><ref type="bibr">20,</ref><ref type="bibr">21 and 22 of patient 1,</ref><ref type="bibr">in TCR Vb1,</ref><ref type="bibr">7,</ref><ref type="bibr">9,</ref><ref type="bibr">11,</ref><ref type="bibr">13,</ref><ref type="bibr">15,</ref><ref type="bibr">17,</ref><ref type="bibr">18,</ref><ref type="bibr">19,</ref><ref type="bibr">21 and</ref> Ž .  24 of patient 2 and in TCR Vb9, 14, 17, 20 and 21 of patient 3. To study if the clonal expansions of T cells in muscle tissue was a localized or systemic phenomenon we compared Vb family repertoire in muscle and blood sam-Ž . ples obtained concomitantly in two patients Fig. <ref type="figure">2b</ref> . Oligoclonal expansions of T cells in muscle tissue were usually not apparent in the corresponding Vb families of PBL, although oligoclonal expansions were apparent also in PBL of the IBM patients.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">Discussion</head><p>In this study the pattern of oligoclonality in muscle infiltrating T cells of IBM patients has for the first time been investigated. The CDR3 size distribution analysis technique used in this investigation gives an overview of most known TCR Vb families and has been shown to be an efficient method in order to identify oligoclonal T cell Ž expansions in healthy and diseased human tissues <ref type="bibr" target="#b23">Puisieux et al., 1994;</ref><ref type="bibr" target="#b5">Even et al., 1995;</ref><ref type="bibr" target="#b8">Gaudin et al., 1995;</ref><ref type="bibr" target="#b14">Liu et al., 1995;</ref><ref type="bibr" target="#b20">Pannetier et al., 1995;</ref><ref type="bibr" target="#b22">Puisieux et al., 1996;</ref><ref type="bibr"></ref> . <ref type="bibr" target="#b24">Valteau et al., 1996</ref> . We found that some muscle infiltrat-ing T cells showed an oligoclonal expansion pattern but that the polyclonal pattern dominated. In addition, we demonstrated that the TCR CDR3 length distribution of PBL investigated in parallel showed a different size spectrum compared to muscle infiltrating T cells expressing the corresponding Vb families. Oligoclonal expansions of PBL Ž is regularly found in healthy elderly individuals <ref type="bibr" target="#b10">Hingorani . et al., 1993;</ref><ref type="bibr" target="#b21">Posnett et al., 1994</ref> and may be due to both environmental and genetic factors. The oligoclonal T cell expansions specific for muscle tissue shown in this study gives further support for the concept that the inflammatory reaction in IBM is a local T cell response to antigenic stimulation. By combined immunohistochemistry and RT-PCR it was recently shown that cytotoxic CD8 q T cells that invaded muscle fibers were clonally restricted, whereas interstitial T cells were clonally diverse in three patients Ž . with <ref type="bibr">IBM Bender et al., 1998 .</ref> Another study on polymyositis has also shown clonal expansion of muscle q Ž . fiber invading CD8 T cells <ref type="bibr" target="#b3">Bender et al., 1995 .</ref> Investigation of oligoclonal populations of T cells may therefore be a method to identify pathogenic T cells that own the ability to invade muscle fibers. Although one Vb family Ž . Vb21 was shown to have an oligoclonal pattern in all three patients studied, most oligoclonally expanded T cells expressed TCR Vb families that differed between the individual IBM patients. This indicates that there is a variability within Vb families with respect to oligoclonality in different patients. In addition, restricted usage of Vb families with variation between individual IBM patients Ž has previously been demonstrated by us and others <ref type="bibr" target="#b12">Lindberg et al., 1994a;</ref><ref type="bibr" target="#b18">O'Hanlon et al., 1994;</ref><ref type="bibr" target="#b7">Fyhr et al., . 1996</ref> .</p><p>The method used in this study may be a potent tool to identify the most important pathogenic T cell clones in an individual with IBM. It has been shown that pathogenic T cell clones in experimental autoimmune encephalomyelitis Ž . EAE are preserved throughout the course of the disease although the phenotype of T cells diversifies as the disease Ž . progresses <ref type="bibr" target="#b11">Kim et al., 1998 .</ref> Elucidating the role of muscle infiltrating T cells in the pathogenesis of IBM could lead to detection of pathogenic T cells and consequently identification of disease eliciting antigens. Such knowledge might increase the possibilities for specific therapy.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc>; O'Hanlon et ) Corresponding author. Department of Pathology, Sahlgrenska University Hospital, S-413 45 Goteborg, Sweden. Tel.: q46 31 602084; fax: q46 31 417283; e-mail: anders.oldfors@path.gu.se</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>.</head><label></label><figDesc></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head></head><label></label><figDesc>Fig. 2. a TCR CDR3 size distribution of 24 Vb families in peripheral Ž . Ž . blood lymphocytes PBL in a healthy 35-year old man. b TCR CDR3 size distribution patterns of 24 Vb families in muscle infiltrating lympho-Ž . Ž . cytes MIL and peripheral blood lymphocytes PBL of patient 1 and 2. The X-axis shows the CDR3 length distribution. The Y-axis shows the fluorescence intensities. The X-axis of MIL and PBL shows the same CDR3 size for every individual Vb family in order to make comparison Ž . between peaks of the fragments possible. c TCR Vb repertoire of Ž . muscle infiltrating lymphocytes MIL in patient 3.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2</head><label>2</label><figDesc></figDesc><table><row><cell>, 2 ml cDNA, 2.5 U AmpliTaq DNA polymerase</cell></row><row><cell>Ž Perkin Elmer, Norwalk, CT , each dNTP at a final con-.</cell></row><row><cell>Ž centration of 200 mM, 5 ml of PCR buffer 15 mM</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 2</head><label>2</label><figDesc>Oligonucleotide primers for PCR of cDNA of Vb families</figDesc><table><row><cell>Vb gene family</cell><cell>X Primer sequences 5 -3 X Ž</cell><cell>.</cell><cell>Fragment size excluding CDR3</cell></row><row><cell>Vb 1</cell><cell cols="2">GCACAACAGTTCCCTGACTTGCAC</cell><cell>168</cell></row><row><cell>Vb 2</cell><cell cols="2">TCATCAACCATGCAAGCCTGACCT</cell><cell>170</cell></row><row><cell>Vb 3</cell><cell cols="2">GTCTCTAGAGAGAAGAGGAGCGC</cell><cell>168</cell></row><row><cell>Vb 4</cell><cell cols="2">ACGATCCAGTGTCAAGTCGAT</cell><cell>312</cell></row><row><cell>Vb 5.1</cell><cell cols="2">ATACTTCAGTGAGACACAGAGA</cell><cell>220</cell></row><row><cell>Vb 5.2</cell><cell cols="2">TTCCCTAACTATAGCTCTGAGCTG</cell><cell>159</cell></row><row><cell>Vb 6</cell><cell cols="2">AGGCCTGAGGGATCCGTCTC</cell><cell>162</cell></row><row><cell>Vb 7</cell><cell cols="2">CCTGAATGCCCCAACAGCTCTC</cell><cell>168</cell></row><row><cell>Vb 8</cell><cell cols="2">ACTTTAACAACAACGTTCCGA</cell><cell>224</cell></row><row><cell>Vb 9</cell><cell cols="2">CTAAATCTCCAGACAAAGCTCAC</cell><cell>167</cell></row><row><cell>Vb 10</cell><cell cols="2">TCCAAAAACTCATCCTGTACCT</cell><cell>159</cell></row><row><cell>Vb 11</cell><cell cols="2">TGTTCTCAAACCATGGGCCATGAC</cell><cell>277</cell></row><row><cell>Vb 12</cell><cell cols="2">GATACTGACAAAGGAGAAGTCTCAGAT</cell><cell>204</cell></row><row><cell>Vb 13</cell><cell cols="2">CTGCAGTGTGCCCAGGAT</cell><cell>303</cell></row><row><cell>Vb 14</cell><cell cols="2">ACCCAAGATACCTCATCACAG</cell><cell>344</cell></row><row><cell>Vb 15</cell><cell cols="2">AGTGTCTCTCGACAGGCACAG</cell><cell>171</cell></row><row><cell>Vb 16</cell><cell cols="2">GACCCAATTTCTGGACATGAT</cell><cell>297</cell></row><row><cell>Vb 17</cell><cell cols="2">TTTCAGAAAGGAGATATAGCT</cell><cell>201</cell></row><row><cell>Vb 18</cell><cell cols="2">AGCCCAATGAAAGGACACAGTCAT</cell><cell>297</cell></row><row><cell>Vb 19</cell><cell cols="2">ACCCCCGAAAAAGGACATACT</cell><cell>297</cell></row><row><cell>Vb 20</cell><cell cols="2">CTCTGAGGTGCCCCAGAA</cell><cell>183</cell></row><row><cell>Vb 21</cell><cell cols="2">CGGAGCTTCTGGTTCAAT</cell><cell>239</cell></row><row><cell>Vb 22</cell><cell cols="2">ATGAAATCTCAGAGAAGTCT</cell><cell>212</cell></row><row><cell>Vb 23</cell><cell cols="2">GATCAGAGAAAAGAGGGAAAC</cell><cell>331</cell></row><row><cell>Vb 24</cell><cell cols="2">CTGCTGTTCCACTACTATGAC</cell><cell>231</cell></row><row><cell>Cb</cell><cell cols="2">TTCTGATGGCTCAAACAC</cell><cell></cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p>We thank professor Andrej Tarkowski for critically reading the manuscript and Ms. Hermengild Barrlind for excellent technical assistance. The study was supported by grants from the Swedish Medical Research Council, project 7122, Gothenburg Medical Society, the Swedish Rheumatism Association and the King Gustaf V 80th Anniversary Fund. ( ) I.-M. Fyhr et al.r Journal of Neuroimmunology 91 1998 129-134  </p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Monoclonal antibody analysis of mononuclear cells in myopathies: V. Identification and quantification of T8 q cytotoxic and T8 q suppressor cells</title>
		<author>
			<persName><forename type="first">K</forename><surname>Arahata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. Neurol</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="493" to="499" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Inclusion body myositis: Explanation for poor response to immunosuppressive therapy</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Barohn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Amato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Sahenk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Kissel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Mendell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="1302" to="1304" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">T-cell heterogeneity in muscle lesions of inclusion body myositis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Bender</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Behrens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hohlfeld</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neuroimmunol</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="86" to="91" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">T cell receptor repertoire in polymyositis: Clonal expansion of autoaggressive CD8 q T cells</title>
		<author>
			<persName><forename type="first">A</forename><surname>Bender</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Ernst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Iglesias</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Dornmair</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wekerle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hohlfeld</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Exp. Med</title>
		<imprint>
			<biblScope unit="volume">181</biblScope>
			<biblScope unit="page" from="1863" to="1868" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Inclusion body myositis, a review</title>
		<author>
			<persName><forename type="first">S</forename><surname>Carpenter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neuropathol. Exp. Neurol</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="1105" to="1114" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">T-cell repertoires in healthy and diseased human tissues analysed by T-cell receptor b-chain CDR3 size determination: evidence for oligoclonal expansions in tumours and inflammatory diseases</title>
		<author>
			<persName><forename type="first">J</forename><surname>Even</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Puisieux</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Res. Immunol</title>
		<imprint>
			<biblScope unit="volume">146</biblScope>
			<biblScope unit="page" from="65" to="80" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Oligoclonal expansion of T cells in muscle in inclusion body myositis</title>
		<author>
			<persName><forename type="first">I.-M</forename><surname>Fyhr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A.-R</forename><surname>Moslemi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mosavi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lindberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tarkowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Oldfors</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neuroimmunol</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="page" from="185" to="189" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Limited T-cell receptor V gene usage in inclusion body myositis</title>
		<author>
			<persName><forename type="first">I.-M</forename><surname>Fyhr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A.-R</forename><surname>Moslemi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tarkowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lindberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Oldfors</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scand. J. Immunol</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="109" to="114" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">In vivo local expansion of clonal T cell subpopulations in renal cell carcinoma</title>
		<author>
			<persName><forename type="first">C</forename><surname>Gaudin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">Y</forename><surname>Dietrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Robache</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Guillard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Escudier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Lacombe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Triebel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Caignard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="685" to="690" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Inclusion body myositis and myopathies</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Griggs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dimauro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Karpati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Mendell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">P</forename><surname>Rowland</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. Neurol</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="705" to="713" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Clonal predominance of T cell receptors within the CD8 q CDRO q subset in normal human subjects</title>
		<author>
			<persName><forename type="first">R</forename><surname>Hingorani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Akolkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Gulwani-Akolkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Pergolizzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Silver</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Gregersen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Immunol</title>
		<imprint>
			<biblScope unit="volume">151</biblScope>
			<biblScope unit="page" from="5762" to="5769" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">CDR3 size spectratyping and sequencing of spectratype-derived TCR of spinal cord T cells in autoimmune encephalomyelitis</title>
		<author>
			<persName><forename type="first">G</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Tanuma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kojima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kohyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Suzuki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kawazoe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Matsumoto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Immunol</title>
		<imprint>
			<biblScope unit="volume">160</biblScope>
			<biblScope unit="page" from="509" to="513" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Restricted use of T cell receptor V genes in endomysial infiltrates of patients with inflammatory myopathies</title>
		<author>
			<persName><forename type="first">C</forename><surname>Lindberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Oldfors</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tarkowski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur. J. Immunol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="2659" to="2663" />
			<date type="published" when="1994">1994a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Inclusion body myositis-clinical, morphological, physiological and laboratory findings in 18 cases</title>
		<author>
			<persName><forename type="first">C</forename><surname>Lindberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Persson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bjorkander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Oldfors</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Neurol. Scand</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="page" from="123" to="131" />
			<date type="published" when="1994">1994b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Intrafamily fragment analysis of the T cell receptor beta chain CDR3 region</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Callahan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Dau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Immunol. Methods</title>
		<imprint>
			<biblScope unit="volume">187</biblScope>
			<biblScope unit="page" from="139" to="150" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Inclusion body myositis. Observations in 40 patients</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">P</forename><surname>Lotz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Nishino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Stevens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Litchy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page" from="727" to="747" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Oligoclonality in the human CD8 q T cell repertoire in normal subjects and monozygotic twins: Implications for studies of infectious and autoimmune diseases</title>
		<author>
			<persName><forename type="first">J</forename><surname>Monteiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hingorani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I.-H</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Silver</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Pergolizzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K</forename><surname>Gregersen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Med</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="614" to="624" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Sequence analysis of the human alpha beta T-cell receptor CDR3 region</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A H</forename><surname>Moss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">I</forename><surname>Bell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunogenetics</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="10" to="18" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">The alpha beta-T-cell receptor repertoire in inclusion body myositis-diverse patterns of gene expression by muscle-infiltrating lymphocytes</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>O'hanlon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Plotz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Miller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Autoimmun</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="321" to="333" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">The sizes of the CDR3 hypervariable regions of the murine T-cell receptor b chains vary as a function of the recombined germ-line segments</title>
		<author>
			<persName><forename type="first">C</forename><surname>Pannetier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cochet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Darche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Casrouge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zoller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kourilsky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci. USA</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="page" from="4319" to="4323" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">T-cell repertoire diversity and clonal expansions in normal and clinical samples</title>
		<author>
			<persName><forename type="first">C</forename><surname>Pannetier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Even</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kourilsky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunol. Today</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="176" to="181" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Clonal population of T cells in normal elderly humans: The T cell equivalent to &apos;benign monoclonal gammapathy</title>
		<author>
			<persName><forename type="first">D</forename><surname>Posnett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Sinha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kabak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Russo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Exp. Med</title>
		<imprint>
			<biblScope unit="volume">179</biblScope>
			<biblScope unit="page" from="609" to="618" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Restriction of the T-cell repertoire in tumor-infiltrating lymphocytes from nine patients with renal-cell carcinoma. Relevance of the CDR3 length analysis for the identification of in situ clonal T-cell expansions</title>
		<author>
			<persName><forename type="first">I</forename><surname>Puisieux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Merrouche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Malacher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kourilsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Even</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Favrot</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int. J. Cancer</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="201" to="208" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Oligoclonality of tumor-infiltrating lymphocytes from human melanomas</title>
		<author>
			<persName><forename type="first">I</forename><surname>Puisieux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Even</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Pannetier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Jotereau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Favrot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kourilsky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Immunol</title>
		<imprint>
			<biblScope unit="volume">153</biblScope>
			<biblScope unit="page" from="2807" to="2818" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">T-cell receptor repertoire in neuroblastoma patients</title>
		<author>
			<persName><forename type="first">D</forename><surname>Valteau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Carcelain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Hartmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Escudier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hercend</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Triebel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="362" to="369" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
